Ongoing Clinical Research Studies
We are currently conducting clinical trials to investigate whether a medication that is routinely used in the treatment of type 2 diabetes (e.g. pioglitazone) can reduce symptoms of depression, reduce abdominal obesity, and improve other aspects of the metabolic syndrome.
To be eligible for participation, you must be diagnosed with depression or bipolar disorder and meet criteria for metabolic syndrome. You will be assessed for these conditions at your clinical intake appointment. Answers to some frequently asked questions about participation in these research studies can be found below. For more information or to schedule an appointment, please call 216-844-2869.
Questions About Clinical Trial Participation
1. Who is eligible to participate?
2. Who is excluded from participation?
3. How long will study participation last?
4. Is there a chance I will receive a placebo or “sugar pill”?
5. Can I still participate if I do not have health insurance?
6. How long will I have to wait before getting an appointment for an initial psychiatric evaluation?
1. Who is eligible to participate?
For our clinical trials studying pioglitazone for the treatment of depression or bipolar depression, men and women between the ages of 18 – 70 may participate.
2. Who is excluded from participation?
If you have a diagnosis of heart failure, you will not be eligible to participate. Also, if you are pregnant or planning to become participate, you will not be able to enroll in this study.
3. How long will study participation last?
The study may last up to 24 weeks for patients with major depression and up to 20 weeks for patients with bipolar depression.
4. Is there a chance I will receive a placebo or “sugar pill”?
No. All patients enrolling in these studies will receive active study medication.
5. Can I still participate if I do not have health insurance?
Yes. All study-related visits are provided at no cost. We also provide 3 routine clinical care visits over 3 months to all patients who participate in any of our research studies. This helps to ensure a smooth transition from the point of exiting a clinical trial to beginning routine care.
6. How long will I have to wait before getting an appointment for an initial psychiatric evaluation?
We are typically able to schedule appointments with a physician within 2 weeks of your call.
|
